Q2 2019 13F Holders as of 30 Jun 2019
-
Type / Class
-
Equity / COM PAR
-
Number of holders
-
22
-
Total 13F shares, excl. options
-
1,661,364
-
Shares change
-
-18,222
-
Total reported value, excl. options
-
$10,800,000
-
Value change
-
-$117,056
-
Number of buys
-
7
-
Number of sells
-
-5
-
Price
-
$6.50
Significant Holders of IMMUCELL CORP /DE/ - COM PAR (ICCC) as of Q2 2019
24 filings reported holding ICCC - IMMUCELL CORP /DE/ - COM PAR as of Q2 2019.
IMMUCELL CORP /DE/ - COM PAR (ICCC) has 22 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 1,661,364 shares
.
Largest 10 shareholders include WELLINGTON MANAGEMENT GROUP LLP (683,334 shares), HEARTLAND ADVISORS INC (199,600 shares), PERRITT CAPITAL MANAGEMENT INC (130,000 shares), Antara Capital LP (105,000 shares), INGALLS & SNYDER LLC (96,243 shares), VANGUARD GROUP INC (93,954 shares), RENAISSANCE TECHNOLOGIES LLC (92,006 shares), Wexford Capital LP (90,000 shares), SHUFRO ROSE & CO LLC (50,670 shares), and HM PAYSON & CO (28,500 shares).
This table shows the top 22 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.